ParkourSC will speak alongside pharmaceutical supply chain experts at Merck, Bristol Myers Squibb and AeroSafe Global BOSTON–(BUSINESS WIRE)–ParkourSC, a leader in supply chain technology solutions, today announced its participation and exhibition at LogiPharma U.S.A., taking place on September 29 – 30, 2022 in Boston, Massachusetts. What: LogiPharma U.S.A. convenes the top minds in life sciences … [Read more…]
Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot removal in peripheral arterial and venous systems, including for diseases such as acute limb ischemia, vein thrombosis and pulmonary embolism First and only computer-aided mechanical aspiration technology that can differentiate … [Read more…]
PHILADELPHIA–(BUSINESS WIRE)–Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced a poster presentation at the 2022 International Cancer Immunotherapy Conference (CICON) in New York City, NY, from September 28 – October 1, 2022. At the meeting, Imvax will present preclinical data that further elucidate the foundational anti-tumor immunological mechanisms of its … [Read more…]
FOOTHILL RANCH, Calif.–(BUSINESS WIRE)–TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy (BNCT), today announced the publication of a study in the September 22 issue of the Journal of Medical Physics that assessed whether alpha particles generated through the combination of boron target drugs and proton radiation would generate … [Read more…]
MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D, President and Chief Scientific Officer of ReCode Therapeutics, will present a company overview at 8:00 a.m. ET on Thursday, September 29, 2022 at the … [Read more…]
Board of Directors approves quarterly cash dividend of $0.40 per share NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 fourth-quarter 2022 dividend on the company’s common stock, payable December 5, 2022, to holders of the Common Stock of record at the close of business on November 4, … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that Sekar Kathiresan, M.D., a Maze co-founder, has joined the company’s board of directors. Dr. Kathiresan is an experienced cardiologist, co-founder and chief executive officer of Verve Therapeutics, and a lecturer in medicine at Harvard Medical School. His … [Read more…]
LAWRENCE, Kan.–(BUSINESS WIRE)–#Endpoints11—Endpoints News, the biopharma industry’s leading source for daily news and analysis, today unveiled the 2022 Endpoints 11 — the most promising biotech startup companies of the year. Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a … [Read more…]
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that the Company will participate in the Jefferies Cell & Genetic Medicine Summit taking place September 29-30, 2022. Details for the company presentation are as follows: Date: … [Read more…]
LINCOLN, Neb. & NEW YORK–(BUSINESS WIRE)–Paradigm Oral Health (“Paradigm”), a leading oral surgery and digital dentistry platform, today announced that BlackRock Long Term Private Capital (“LTPC”) has entered into a definitive agreement to acquire a majority interest in the company from shareholders including InTandem Capital Partners. LTPC will partner with Paradigm’s executive leadership team, led … [Read more…]
